Kevin J. Cullen
Directeur/Membre du Conseil chez University of Maryland Marlene & Stewart Greenebaum Cancer
Profil
Kevin J.
Cullen is currently the Director at the University of Maryland Marlene & Stewart Greenebaum Cancer and a Professor at the University of Maryland School of Medicine.
He was previously the Chairman at the American Cancer Society, Inc. and the Director at Georgetown Lombardi Comprehensive Cancer Center.
He also held the position of Professor at Georgetown University School of Medicine.
Dr. Cullen received his undergraduate degree from Dartmouth College and his doctorate from Harvard Medical School.
Postes actifs de Kevin J. Cullen
| Sociétés | Poste | Début |
|---|---|---|
| University of Maryland School of Medicine | Corporate Officer/Principal | - |
| University of Maryland Marlene & Stewart Greenebaum Cancer | Directeur/Membre du Conseil | 01/01/2004 |
Anciens postes connus de Kevin J. Cullen
| Sociétés | Poste | Fin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/01/2023 |
| Georgetown University School of Medicine | Corporate Officer/Principal | 01/01/2004 |
Georgetown Lombardi Comprehensive Cancer Center
 Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Directeur/Membre du Conseil | 01/09/2002 |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Président | - |
Formation de Kevin J. Cullen
| Dartmouth College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Commercial Services |
| University of Maryland Marlene & Stewart Greenebaum Cancer | |
Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Health Services |